Table 3 Demographics of study subjects (N = 339)
Characteristics | Overall | CRC n (%) | Advanced adenomas n (%) | Non‐advanced adenoma n (%) | Colitis n (%) | Normal control n (%) | P value |
|---|---|---|---|---|---|---|---|
Number | 339 | 102 | 50 | 39 | 18 | 130 | |
Gender | 0.054 | ||||||
Male | 173 (51.03%) | 50 (49.02%) | 35 (70.00%) | 19 (48.72%) | 10 (55.56%) | 59 (45.38%) | |
Female | 166 (48.97%) | 52 (50.98%) | 15 (30.00%) | 20 (51.28%) | 8 (44.44%) | 71 (54.62%) | |
Median age (years, range) | < 0.001 | ||||||
< 35 | 40 (11.81%) | 3 (2.94%) | 2 (4.00%) | 4 (10.26%) | 5 (27.78%) | 26 (20.00%) | |
35–45 | 47 (13.86%) | 10 (9.80%) | 1 (2.00%) | 1 (2.56%) | 4 (22.22%) | 31 (23.85%) | |
46–55 | 65 (19.17%) | 13 (12.75%) | 12 (24.00%) | 13 (33.33%) | 4 (22.22%) | 23 (17.69%) | |
> 55 | 187 (55.16%) | 76 (74.51%) | 35 (70.00%) | 21 (53.85%) | 5 (27.78%) | 50 (38.46%) | |
Clinical stage | / | ||||||
0 | / | 4 (3.92%) | / | / | / | / | |
I | / | 11 (10.78%) | / | / | / | / | |
II | / | 28 (27.45%) | / | / | / | / | |
III | / | 34 (33.34%) | / | / | / | / | |
IV | / | 2 (1.96%) | / | / | / | / | |
Not determined | / | 23 (22.55%) | / | / | / | / |